首页 › 慢性阻塞性肺病 › 得克萨斯州 › Cypress
Cypress TX 慢性阻塞性肺病临床试验
4项针对 慢性阻塞性肺病的研究正在 Cypress及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
招募中3 期
- Syri Research Center- Site Number : 8400069, Cypress
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
招募中2/3 期
- Horizon Clinical Research Group, Cypress
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
招募中2 期
- Horizon Clinical Research Group., Cypress
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
招募中3 期
- GSK Investigational Site, Katy · 距离 15 英里
其他城市的 慢性阻塞性肺病试验
- Philadelphia, PA22 项研究
- Birmingham, AL18 项研究
- Miami, FL18 项研究
- Boston, MA17 项研究
- Houston, TX15 项研究
- Orlando, FL15 项研究
- Chicago, IL14 项研究
- Pittsburgh, PA13 项研究
- Baltimore, MD13 项研究
- Dallas, TX12 项研究
- New York City, NY11 项研究
- Ann Arbor, MI10 项研究
Cypress的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。